Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid

This publication has 12 references indexed in Scilit:

• Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial.
  Journal of Clinical Oncology, 1989
• Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.
  Journal of Clinical Oncology, 1989
• Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
  Journal of Clinical Oncology, 1989
• A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A mayo clinic/north central cancer treatment group study
  Cancer, 1989
• Prognostic factors of advanced colorectal cancer patients
  European Journal of Cancer and Clinical Oncology, 1986
• Prognostic factors in advanced colorectal carcinoma
  The American Journal of Medicine, 1983
• Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum
  Diseases of the Colon & Rectum, 1982
• Natural history of patients with untreated liver metastases from colorectal cancer
  The American Journal of Surgery, 1981
• Survival and response to chemotherapy for advanced colorectal adenocarcinoma. An eastern cooperative oncology group report
  Cancer, 1980
• The natural history of primary and secondary malignant tumors of the liver I.The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy
  Cancer, 1969